tradingkey.logo
tradingkey.logo
Search

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval For A Phase 1B/2 Clinical Trial Of Soquelitinib

ReutersJun 25, 2025 12:25 PM
facebooktwitterlinkedin

- Corvus Pharmaceuticals Inc CRVS.O:

  • CORVUS PHARMACEUTICALS ANNOUNCES PARTNER ANGEL PHARMACEUTICALS RECEIVED IND APPROVAL FOR A PHASE 1B/2 CLINICAL TRIAL OF SOQUELITINIB IN CHINA FOR THE TREATMENT OF ATOPIC DERMATITIS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI